Evidence map›Paper›PMID 24630793›Full record

ArticleCell stem cell2014

Multifaceted regulation of somatic cell reprogramming by mRNA translational control.

Soroush Tahmasebi, Tommy Alain, Vinagolu K Rajasekhar, Jiang-Ping Zhang, Masha Prager-Khoutorsky, Arkady Khoutorsky, Yildirim Dogan, Christos G Gkogkas, Emmanuel Petroulakis, Annie Sylvestre and 8 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Cell stem cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 57 citations in OpenAlex.

  1. [Systemic Reprogramming of Cellular Senescence: Coordinated Regulation of Metabolism, Epigenetics, and Proteostasis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Translational control of stem cell function.Nature reviews. Molecular cell biology · 2021
    Review
  18. 5'-UTR SNP ofeLife · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Soroush TahmasebiThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada.
Tommy AlainChildren's Hospital of Eastern Ontario Research Institute and Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
Vinagolu K RajasekharDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Jiang-Ping ZhangThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University Health Center, Montréal, QC H3A 1A3, Canada.
Masha Prager-KhoutorskyCentre for Research in Neuroscience, Research Institute of the McGill University Health Centre, Montréal General Hospital, Montréal, QC H3G 1A4, Canada.
Arkady KhoutorskyThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada.
Yildirim DoganCancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Christos G GkogkasPatrick Wild Centre, Centre for Integrative Physiology, University of Edinburgh, Edinburgh EH8 9XD, UK.
Emmanuel PetroulakisThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada.
Annie SylvestreThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada.
Mohammad GhorbaniThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University Health Center, Montréal, QC H3A 1A3, Canada.
Sarah AssadianThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada.
Yojiro YamanakaThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Human Genetics, McGill University, Montréal, QC H3A 1A3, Canada.
Julia R Vinagolu-BaurCancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jose G TeodoroThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada.
Kitai KimCancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Xiang-Jiao YangThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University Health Center, Montréal, QC H3A 1A3, Canada. Electronic address: xiang-jiao.yang@mcgill.ca.
Nahum SonenbergThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University Health Center, Montréal, QC H3A 1A3, Canada. Electronic address: nahum.sonenberg@mcgill.ca.
McGill University · CAMcGill University Health Centre · CAMemorial Sloan Kettering Cancer Center · USChildren's Hospital of Eastern Ontario · CAUniversity of Edinburgh · GB

Funding

Canadian Institutes of Health Research MOP-111197Canadian Institutes of Health Research MOP-115195
6 · The paper itself

Abstract

Translational control plays a pivotal role in the regulation of the pluripotency network in embryonic stem cells, but its effect on reprogramming somatic cells to pluripotency has not been explored. Here, we show that eukaryotic translation initiation factor 4E (eIF4E) binding proteins (4E-BPs), which are translational repressors, have a multifaceted effect on the reprogramming of mouse embryonic fibroblasts (MEFs) into induced pluripotent stem cells (iPSCs). Loss of 4E-BP expression attenuates the induction of iPSCs at least in part through increased translation of p21, a known inhibitor of somatic cell reprogramming. However, MEFs lacking both p53 and 4E-BPs show greatly enhanced reprogramming resulting from a combination of reduced p21 transcription and enhanced translation of endogenous mRNAs such as Sox2 and Myc and can be reprogrammed through the expression of only exogenous Oct4. Thus, 4E-BPs exert both positive and negative effects on reprogramming, highlighting the key role that translational control plays in regulating this process.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarrier ProteinsCell Cycle ProteinsCells, CulturedCellular ReprogrammingEmbryonic Stem CellsEukaryotic Initiation FactorsInduced Pluripotent Stem CellsMiceModels, BiologicalPhosphoproteinsProto-Oncogene Proteins c-mycSOXB1 Transcription FactorsAdaptor Proteins, Signal TransducingCarrier ProteinsCell Cycle ProteinsEif4ebp1 protein, mouseEif4ebp2 protein, mouseEukaryotic Initiation FactorsMyc protein, mousePhosphoproteinsProto-Oncogene Proteins c-mycSOXB1 Transcription Factors

Identifiers

PMID24630793
OpenAlexW1984589010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.